189 related articles for article (PubMed ID: 27080907)
1. Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma.
Lennon FE; Cianci GC; Kanteti R; Riehm JJ; Arif Q; Poroyko VA; Lupovitch E; Vigneswaran W; Husain A; Chen P; Liao JK; Sattler M; Kindler HL; Salgia R
Sci Rep; 2016 Apr; 6():24578. PubMed ID: 27080907
[TBL] [Abstract][Full Text] [Related]
2. Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells.
Valenti D; de Bari L; Manente GA; Rossi L; Mutti L; Moro L; Vacca RA
Biochim Biophys Acta; 2013 Dec; 1832(12):2085-96. PubMed ID: 23911347
[TBL] [Abstract][Full Text] [Related]
3. Pifithrin-μ induces necroptosis through oxidative mitochondrial damage but accompanies epithelial-mesenchymal transition-like phenomenon in malignant mesothelioma cells under lactic acidosis.
Lee YJ; Park KS; Heo SH; Nam HS; Cho MK; Lee SH
Arch Pharm Res; 2019 Oct; 42(10):890-901. PubMed ID: 31428976
[TBL] [Abstract][Full Text] [Related]
4. Peroxiredoxin 3 levels regulate a mitochondrial redox setpoint in malignant mesothelioma cells.
Cunniff B; Wozniak AN; Sweeney P; DeCosta K; Heintz NH
Redox Biol; 2014; 3():79-87. PubMed ID: 25462069
[TBL] [Abstract][Full Text] [Related]
5. Disabling Mitochondrial Peroxide Metabolism via Combinatorial Targeting of Peroxiredoxin 3 as an Effective Therapeutic Approach for Malignant Mesothelioma.
Cunniff B; Newick K; Nelson KJ; Wozniak AN; Beuschel S; Leavitt B; Bhave A; Butnor K; Koenig A; Chouchani ET; James AM; Haynes AC; Lowther WT; Murphy MP; Shukla A; Heintz NH
PLoS One; 2015; 10(5):e0127310. PubMed ID: 26011724
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial function.
Tomasetti M; Nocchi L; Staffolani S; Manzella N; Amati M; Goodwin J; Kluckova K; Nguyen M; Strafella E; Bajzikova M; Peterka M; Lettlova S; Truksa J; Lee W; Dong LF; Santarelli L; Neuzil J
Antioxid Redox Signal; 2014 Nov; 21(15):2109-25. PubMed ID: 24444362
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria-derived reactive oxygen species drive GANT61-induced mesothelioma cell apoptosis.
Lim CB; Prêle CM; Baltic S; Arthur PG; Creaney J; Watkins DN; Thompson PJ; Mutsaers SE
Oncotarget; 2015 Jan; 6(3):1519-30. PubMed ID: 25544756
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial-targeted nitroxides disrupt mitochondrial architecture and inhibit expression of peroxiredoxin 3 and FOXM1 in malignant mesothelioma cells.
Cunniff B; Benson K; Stumpff J; Newick K; Held P; Taatjes D; Joseph J; Kalyanaraman B; Heintz NH
J Cell Physiol; 2013 Apr; 228(4):835-45. PubMed ID: 23018647
[TBL] [Abstract][Full Text] [Related]
9. Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro.
Hoda MA; Pirker C; Dong Y; Schelch K; Heffeter P; Kryeziu K; van Schoonhoven S; Klikovits T; Laszlo V; Rozsas A; Ozsvar J; Klepetko W; Döme B; Grusch M; Hegedüs B; Berger W
Mol Cancer Ther; 2016 Oct; 15(10):2357-2369. PubMed ID: 27512118
[TBL] [Abstract][Full Text] [Related]
10. Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma.
Villanova T; Gesmundo I; Audrito V; Vitale N; Silvagno F; Musuraca C; Righi L; Libener R; Riganti C; Bironzo P; Deaglio S; Papotti M; Cai R; Sha W; Ghigo E; Schally AV; Granata R
Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2226-2231. PubMed ID: 30659154
[TBL] [Abstract][Full Text] [Related]
11. Inflammasome Modulation by Chemotherapeutics in Malignant Mesothelioma.
Westbom C; Thompson JK; Leggett A; MacPherson M; Beuschel S; Pass H; Vacek P; Shukla A
PLoS One; 2015; 10(12):e0145404. PubMed ID: 26689911
[TBL] [Abstract][Full Text] [Related]
12. Enhanced apoptosis by pemetrexed and simvastatin in malignant mesothelioma and lung cancer cells by reactive oxygen species-dependent mitochondrial dysfunction and Bim induction.
Hwang KE; Kim YS; Hwang YR; Kwon SJ; Park DS; Cha BK; Kim BR; Yoon KH; Jeong ET; Kim HR
Int J Oncol; 2014 Oct; 45(4):1769-77. PubMed ID: 25096993
[TBL] [Abstract][Full Text] [Related]
13. In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma.
Muscella A; Vetrugno C; Cossa LG; Antonaci G; De Nuccio F; De Pascali SA; Fanizzi FP; Marsigliante S
PLoS One; 2016; 11(11):e0165154. PubMed ID: 27806086
[TBL] [Abstract][Full Text] [Related]
14. JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells.
Zanellato I; Colangelo D; Osella D
Curr Cancer Drug Targets; 2018; 18(8):816-828. PubMed ID: 28669341
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin and resveratrol induce apoptosis and autophagy following oxidative stress in malignant mesothelioma cells.
Lee YJ; Lee GJ; Yi SS; Heo SH; Park CR; Nam HS; Cho MK; Lee SH
Food Chem Toxicol; 2016 Nov; 97():96-107. PubMed ID: 27591926
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia.
Li Z; Jiang L; Chew SH; Hirayama T; Sekido Y; Toyokuni S
Redox Biol; 2019 Sep; 26():101297. PubMed ID: 31442913
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma.
Di Marzo D; Forte IM; Indovina P; Di Gennaro E; Rizzo V; Giorgi F; Mattioli E; Iannuzzi CA; Budillon A; Giordano A; Pentimalli F
Cell Cycle; 2014; 13(4):652-65. PubMed ID: 24345738
[TBL] [Abstract][Full Text] [Related]
18. ADP sensitizes ZL55 cells to the activity of cisplatin.
Muscella A; Cossa LG; Vetrugno C; Antonaci G; Marsigliante S
J Cell Physiol; 2019 Apr; 234(4):4409-4417. PubMed ID: 30144378
[TBL] [Abstract][Full Text] [Related]
19. Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways.
Shimazu K; Tada Y; Morinaga T; Shingyoji M; Sekine I; Shimada H; Hiroshima K; Namiki T; Tatsumi K; Tagawa M
BMC Cancer; 2017 May; 17(1):309. PubMed ID: 28464864
[TBL] [Abstract][Full Text] [Related]
20. Fer and FerT Govern Mitochondrial Susceptibility to Metformin and Hypoxic Stress in Colon and Lung Carcinoma Cells.
Marciano O; Mehazri L; Shpungin S; Varvak A; Zacksenhaus E; Nir U
Cells; 2021 Jan; 10(1):. PubMed ID: 33430475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
